Does neoadjuvant chemotherapy improve survival in patients with resectable thoracic oesophageal cancer?
Raja, Shahzad G
Does neoadjuvant chemotherapy improve survival in patients with resectable thoracic oesophageal cancer? [electronic resource] - Interactive cardiovascular and thoracic surgery Oct 2007 - 661-4 p. digital
Publication Type: Journal Article; Meta-Analysis; Review
1569-9285
10.1510/icvts.2007.163386 doi
Adenocarcinoma--drug therapy
Adult
Antineoplastic Agents--therapeutic use
Benchmarking
Carcinoma, Squamous Cell--drug therapy
Chemotherapy, Adjuvant
Esophageal Neoplasms--drug therapy
Esophagectomy
Evidence-Based Medicine
Humans
Male
Neoadjuvant Therapy
Odds Ratio
Practice Guidelines as Topic
Proportional Hazards Models
Risk Assessment
Survival Analysis
Time Factors
Treatment Outcome
Does neoadjuvant chemotherapy improve survival in patients with resectable thoracic oesophageal cancer? [electronic resource] - Interactive cardiovascular and thoracic surgery Oct 2007 - 661-4 p. digital
Publication Type: Journal Article; Meta-Analysis; Review
1569-9285
10.1510/icvts.2007.163386 doi
Adenocarcinoma--drug therapy
Adult
Antineoplastic Agents--therapeutic use
Benchmarking
Carcinoma, Squamous Cell--drug therapy
Chemotherapy, Adjuvant
Esophageal Neoplasms--drug therapy
Esophagectomy
Evidence-Based Medicine
Humans
Male
Neoadjuvant Therapy
Odds Ratio
Practice Guidelines as Topic
Proportional Hazards Models
Risk Assessment
Survival Analysis
Time Factors
Treatment Outcome